Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in
John Gagliano

John GaglianoUnclaimed

Host of Biotech Bulls & Breakthroughs.

3PodCred credits

3 Feed-stated

Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record

  • Host

Claim this profile+ Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.

This is not me · Request removal

+ FollowConnectMessage

This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.

About this profile

Profile
Unclaimed
Shows now
1

People also viewed

  • Annalee Armstrong
  • Billy Henry
  • CS Sheffield (Sheff)

PodCred record

PodCred is the verified record of where John has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.

Worked with John on a show? This is where you give them credit.

+ Add a credit

Shows they work on now

1 show

  • Biotech Bulls & Breakthroughs
    host Feed-stated

Is an appearance missing?

People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.

No account needed. Anyone can give a credit.

Add an appearanceHow PodCred works

Experience, education, skills, and recommendations start empty. They fill in when John claims this profile.

Recommendations

ReceivedGiven

John has not written any yet.

Recommendations open once John claims the profile.

Posts

No posts yet. Posts John shares on PodSubs, and what John publishes on Substack, YouTube and elsewhere, will show here.

Recent episodes

From the shows they work on now

10 episodes
  • Biotech Stocks to Watch: FDA Shakeups, ESMO Data & Late 2026 Biotech Catalysts Sheff Is Watching

    Biotech Bulls & Breakthroughs

    Oct 16, 202646 minAudio

    The FDA is in flux, ESMO is approaching, and a series of clinical and regulatory catalysts could put biotech stocks in focus. John Gagliano and Sheff Sheffield mark their 20th episode together by reviewing developments...

  • Biotech Stocks to Watch: The September – December Catalysts Sheff Is Watching

    Biotech Bulls & Breakthroughs

    Sep 11, 202652 minAudio

    In this episode, John Gagliano and Sheff Sheffield discuss the biggest biotech catalysts heading into the final months of 2026. They examine continued big-pharma acquisition activity, Novo Nordisk’s pediatric obesity...

  • Lithium, brain imaging, & the future of Alzheimer’s treatment with Alzamend CEO Stephan Jackman ALZN

    Biotech Bulls & Breakthroughs

    Aug 26, 202626 minAudio

    In this episode features John Gagliano in conversation with Stephan Jackman, CEO and director of Alzamend, about the company’s mission, “Making Alzheimer’s just a memory,” and its pipeline in Alzheimer’s and related...

  • Biotech Stocks Catalyst to Watch Fall 2026: The Surprising Impact of FDA Adcom Meetings

    Biotech Bulls & Breakthroughs

    Jul 29, 202644 minAudio

    In this episode, John Gagliano and Sheff Sheffield unlock hidden strategies behind biotech success, from FDA decision dynamics to the most promising upcoming catalysts; they reveal how savvy investors spot opportunities...

  • Middle to 3Q 2026 Biotech Catalyst: FDA Policy Shifts and Their Impact on Biotech Stocks

    Biotech Bulls & Breakthroughs

    Jun 24, 20261 hr 1 minAudio

    In this episode, John Gagliano and Sheff Sheffield discuss recent developments in biotech, including FDA policy shifts, key catalysts for upcoming biotech stocks, and market trends amidst frothy conditions. Essential...

  • The Hidden Power of One Pivotal Trial That Changed FDA’s Game | Biotech Bulls & Breakthroughs

    Biotech Bulls & Breakthroughs

    May 28, 202656 minAudio

    In this episode, John Gagliano and Sheff Sheffield unpack the game-changing FDA decision that could add millions to Outlook Therapeutics’ valuation overnight. You'll discover how a small biotech overcame years of...

  • Biotech Investing: Biotech Mid 2026 Catalysts To Watch

    Biotech Bulls & Breakthroughs

    Apr 23, 20261 hr 5 minAudio

    In this episode, as the biotech earnings season continues, John Gagliano and Sheff Sheffield explore the resilience of the biotech market, the impact of FDA policies, and the significance of conferences like AACR and...

  • The Future of Biomanufacturing | Michael Heltzen, eXoZymes

    Biotech Bulls & Breakthroughs

    Apr 13, 202632 minAudio

    In this episode of Biotech Bulls & Breakthroughs, John sits down with Michael Heltzen, CEO of exoZymes, to discuss the revolutionary move toward cell-free biomanufacturing. Discover how exoZymes is using AI to bypass...

  • Biotech Investing: FDA One Pivotal Trial and 2Q Outlook | Biotech Bulls & Breakthroughs

    Biotech Bulls & Breakthroughs

    Mar 25, 202638 minAudio

    In this episode, as the biotech earnings season continues, John Gagliano and Sheff Sheffield dive deep into the new FDA one pivotal trial as an alternative to the regulatory pathway, and what it means for trial...

  • Tackling Rare Genetic Diseases with Diagonal Therapeutics

    Biotech Bulls & Breakthroughs

    Mar 10, 202620 minAudio

    In this episode, John Gagliano speaks with Eric Duhaime, Senior VP of Finance and Corporate Development at Diagonal Therapeutics, about the innovative approaches the company is taking in drug development, with a...

Showing 5 of 10
Report this profile